WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 462334
Description: MTH1-IN-2 is a MutT homolog 1 (MTH1) inhibitor. It can be used for the research of cancer and has anti-tumor activity.
MedKoo Cat#: 462334
Chemical Formula: C24H27N3O5S
Exact Mass: 469.1671
Molecular Weight: 469.556
Elemental Analysis: C, 61.39; H, 5.80; N, 8.95; O, 17.04; S, 6.83
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: MTH1-IN-2; MTH1 IN-2; MTH1-IN 2; MTH1 IN 2; MutT homolog 1 inhibitor 2
IUPAC/Chemical Name: 6-(N-(3-methoxyphenyl)sulfamoyl)-N-(2-methylcyclohexyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
InChi Key: VCILMZPEQSXJDM-UHFFFAOYSA-N
InChi Code: InChI=1S/C24H27N3O5S/c1-15-6-3-4-9-21(15)26-24(29)20-14-25-22-11-10-18(13-19(22)23(20)28)33(30,31)27-16-7-5-8-17(12-16)32-2/h5,7-8,10-15,21,27H,3-4,6,9H2,1-2H3,(H,25,28)(H,26,29)
SMILES Code: O=C(NC1C(CCCC1)C)C2=CNC3=C(C2=O)C=C(C=C3)S(=O)(NC4=CC=CC(OC)=C4)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 469.556 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Kilian Huber. Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer. WO2016135138A1.